ArticleEuropean journal of neurology2025
Variably Defined Conduction Block, Temporal Dispersion and Other Electrophysiological Abnormalities in Multifocal Motor Neuropathy: A Multicentre Study.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Refining Electrophysiological Criteria in CIDP and MMN: Toward a Unified Definition of Motor Conduction Block and Proximal Temporal Dispersion.European journal of neurology · 2026Article
- Conduction Block Detection in Dysimmune Neuropathy: Hypothetical Pathophysiological 'Truth' Versus Clinical Pragmatism.European journal of neurology · 2026Article
- Variably Defined Conduction Block, Temporal Dispersion and Other Electrophysiological Abnormalities in Multifocal Motor Neuropathy: A Multicentre Study.European journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe definition of conduction block (CB) is variable in multifocal motor neuropathy (MMN). In current criteria, excessive temporal dispersion (TD) may preclude the recognition of CB and the diagnosis of MMN.
methodsWe retrospectively studied the electrophysiological data of 47 consecutive subjects with MMN and of 69 consecutive controls with upper limb-onset motor neuron disease, from three neuromuscular centres in the United Kingdom and Korea.
resultsCompared to CB defined by compound muscle action potential (CMAP) area reduction (CB-Area) > 30%, CB defined by CMAP amplitude reduction (CB-amp) > 30% was more sensitive (78.7% vs. 63.8%; McNemar's Test: p = 0.008), but less specific versus controls (90.1% vs. 96.7%; McNemar's Test: p = 0.001). CB-amp > 30% offered greater diagnostic accuracy than CB-Area > 30% (Youden's Index: 0.688 vs. 0.606). TD showed a sensitivity of 59.6% and specificity of 94.3%. F-wave prolongation or absence showed a sensitivity of 42.6% and specificity of 96.9%. Considering CB-amp > 30% or TD or F-wave prolongation or absence, as independent electrodiagnostic markers of MMN, improved diagnostic sensitivity from 78.7% to 91.5% compared to CB-amp > 30% alone (McNemar's Test: p = 0.031), also offering optimal accuracy (Youden's Index: 0.816). Within this three-parameter combination, CB defined by CMAP amplitude reduction > 30% offered similar sensitivity, specificity and accuracy to when defined by CMAP amplitude reduction > 50%.
conclusionsCB-amp has higher sensitivity and accuracy than CB-Area for the electrodiagnosis of MMN. Consideration of TD or F-wave prolongation or absence, as independently diagnostic of MMN, in addition to CB-amp > 30% alone, may improve electrophysiological sensitivity as well as accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.